Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP556457.RAmIO60b16l23NUaUPV6KI8XO_9MkUO3947pdnGX4ZjoA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP556457.RAmIO60b16l23NUaUPV6KI8XO_9MkUO3947pdnGX4ZjoA130_assertion type Assertion NP556457.RAmIO60b16l23NUaUPV6KI8XO_9MkUO3947pdnGX4ZjoA130_head.
- NP556457.RAmIO60b16l23NUaUPV6KI8XO_9MkUO3947pdnGX4ZjoA130_assertion wasGeneratedBy ECO_0000203 NP556457.RAmIO60b16l23NUaUPV6KI8XO_9MkUO3947pdnGX4ZjoA130_provenance.
- NP556457.RAmIO60b16l23NUaUPV6KI8XO_9MkUO3947pdnGX4ZjoA130_assertion wasDerivedFrom befree-2016 NP556457.RAmIO60b16l23NUaUPV6KI8XO_9MkUO3947pdnGX4ZjoA130_provenance.
- NP556457.RAmIO60b16l23NUaUPV6KI8XO_9MkUO3947pdnGX4ZjoA130_assertion SIO_000772 16799619 NP556457.RAmIO60b16l23NUaUPV6KI8XO_9MkUO3947pdnGX4ZjoA130_provenance.
- NP556457.RAmIO60b16l23NUaUPV6KI8XO_9MkUO3947pdnGX4ZjoA130_assertion evidence source_evidence_literature NP556457.RAmIO60b16l23NUaUPV6KI8XO_9MkUO3947pdnGX4ZjoA130_provenance.
- NP556457.RAmIO60b16l23NUaUPV6KI8XO_9MkUO3947pdnGX4ZjoA130_assertion description "[The second set of genetic alterations are etiological nonspecific, it includes recurrent gains and losses of chromosomes, alteration of TP53 gene, activation of WNT/beta-catenin pathway through CTNNB1/beta-catenin and AXIN (axis inhibition protein) mutations, inactivation of retinoblastoma and IGF2R (insulin-like growth factor 2 receptor) pathways through inactivation of RB1 (retinoblastoma 1), P16 and IGF2R.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556457.RAmIO60b16l23NUaUPV6KI8XO_9MkUO3947pdnGX4ZjoA130_provenance.